Case report: Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: a report of 2 cases
IntroductionEfgartigimod has been approved for the treatment of acetylcholine receptor antibodies-positive generalized myasthenia gravis (AChR-Ab+gMG), but its efficacy in patients with ocular myasthenia gravis (OMG) is not known.Case presentationWe de…